Vistos (419540) has 2 disclosed insider purchases and 44 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩631M ($438K) in reported transaction value. The earliest filing StockDrifts holds for Vistos is dated 2023-03-29; the most recent is 2026-06-18. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +18.82%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | BUY | 제3자배정유상증자 | 씨유메디칼 CU Medical | - | 1.4M | ₩3,170 | -5.5% | ₩4.3B ($3.0M) |
| 2026-06-05 | BUY | Market Buy | 씨유메디칼 CU Medical | - | 9.9K | ₩2,800 | +14.3% | ₩28M ($19K) |
| 2026-05-20 | SELL | 주식병합 | 씨유메디칼 CU Medical | - | -6.2M | ₩4,385 | +27.0% | ₩27.3B ($19.0M) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -85 | ₩1,300 | +20.1% | ₩111K ($77) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -40.0K | ₩1,300 | +20.1% | ₩52M ($36K) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -34.0K | ₩1,300 | +20.1% | ₩44M ($31K) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -240 | ₩1,300 | +20.1% | ₩312K ($217) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -40.7K | ₩1,300 | +20.1% | ₩53M ($37K) |
| 2026-01-21 | SELL | Market Sell | 이한나 Hanna Lee | moving | -10.0K | ₩1,300 | +20.1% | ₩13M ($9K) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -20.0K | ₩1,300 | +20.1% | ₩26M ($18K) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -10.3K | ₩1,300 | +20.1% | ₩13M ($9K) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -10.0K | ₩1,300 | +20.1% | ₩13M ($9K) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -9.8K | ₩1,300 | +20.1% | ₩13M ($9K) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -7.9K | ₩1,300 | +20.1% | ₩10M ($7K) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.5K | ₩1,300 | +20.1% | ₩2M ($1K) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -339 | ₩1,300 | +20.1% | ₩441K ($306) |
| 2026-01-21 | SELL | Market Sell | 박승기 Seunggi Park | moving | -293 | ₩1,300 | +20.1% | ₩381K ($265) |
| 2026-01-20 | SELL | 장외매도 | 이후정 Lee Hu-jeong | CEO | -4.5M | ₩1,070 | +3.0% | ₩4.8B ($3.4M) |
| 2026-01-20 | BUY | 장외매수 | 씨유메디칼 CU Medical | - | 7.8M | ₩1,070 | -3.0% | ₩8.3B ($5.8M) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.0K | ₩1,156 | +10.2% | ₩1M ($803) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.0K | ₩1,156 | +10.2% | ₩1M ($803) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.0K | ₩1,156 | +10.2% | ₩1M ($803) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.0K | ₩1,156 | +10.2% | ₩1M ($803) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.0K | ₩1,156 | +10.2% | ₩1M ($803) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.0K | ₩1,156 | +10.2% | ₩1M ($803) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.0K | ₩1,156 | +10.2% | ₩1M ($803) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -2.0K | ₩1,156 | +10.2% | ₩2M ($2K) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -2.0K | ₩1,156 | +10.2% | ₩2M ($2K) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -4.0K | ₩1,156 | +10.2% | ₩5M ($3K) |
| 2025-12-15 | SELL | Market Sell | 박승기 Seunggi Park | moving | -5.0K | ₩1,156 | +10.2% | ₩6M ($4K) |
| 2025-12-12 | SELL | Market Sell | 박승기 Seunggi Park | moving | -291 | ₩1,145 | +9.3% | ₩333K ($231) |
| 2025-12-12 | SELL | Market Sell | 박승기 Seunggi Park | moving | -5.3K | ₩1,145 | +9.3% | ₩6M ($4K) |
| 2025-12-12 | SELL | Market Sell | 박승기 Seunggi Park | moving | -3.1K | ₩1,145 | +9.3% | ₩4M ($2K) |
| 2025-12-12 | SELL | Market Sell | 박승기 Seunggi Park | moving | -2.7K | ₩1,145 | +9.3% | ₩3M ($2K) |
| 2025-12-12 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.5K | ₩1,145 | +9.3% | ₩2M ($1K) |
| 2025-12-12 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.3K | ₩1,145 | +9.3% | ₩2M ($1K) |
| 2025-12-12 | SELL | Market Sell | 박승기 Seunggi Park | moving | -726 | ₩1,145 | +9.3% | ₩831K ($577) |
| 2025-12-10 | SELL | Market Sell | 박승기 Seunggi Park | moving | -588 | ₩1,122 | +7.5% | ₩660K ($458) |
| 2025-12-10 | SELL | Market Sell | 박승기 Seunggi Park | moving | -10.0K | ₩1,122 | +7.5% | ₩11M ($8K) |
| 2025-12-10 | SELL | Market Sell | 박승기 Seunggi Park | moving | -3.1K | ₩1,122 | +7.5% | ₩4M ($2K) |
| 2025-12-10 | SELL | Market Sell | 박승기 Seunggi Park | moving | -1.3K | ₩1,122 | +7.5% | ₩1M ($990) |
| 2024-09-26 | SELL | Market Sell | 강명진 Kang Myeong-jin | Managing Director | -6.5K | ₩2,180 | +52.4% | ₩14M ($10K) |
| 2024-09-25 | SELL | Market Sell | 강명진 Kang Myeong-jin | Managing Director | -11.0K | ₩2,165 | +52.1% | ₩24M ($17K) |
| 2024-09-24 | SELL | Market Sell | 강명진 Kang Myeong-jin | Managing Director | -28.0K | ₩2,205 | +52.9% | ₩62M ($43K) |
| 2024-09-23 | SELL | Market Sell | 강명진 Kang Myeong-jin | Managing Director | -11.5K | ₩2,145 | +51.6% | ₩25M ($17K) |
| 2024-09-23 | BUY | Market Buy | 강명진 Kang Myeong-jin | Managing Director | 1.0K | ₩2,145 | -51.6% | ₩2M ($1K) |
| 2024-09-20 | SELL | Market Sell | 강명진 Kang Myeong-jin | Managing Director | -41.8K | ₩2,180 | +52.4% | ₩91M ($63K) |
| 2024-09-19 | SELL | Market Sell | 강명진 Kang Myeong-jin | Managing Director | -16.0K | ₩2,130 | +51.3% | ₩34M ($24K) |
| 2024-09-13 | SELL | Market Sell | 강명진 Kang Myeong-jin | Managing Director | -20.7K | ₩2,080 | +50.1% | ₩43M ($30K) |
| 2024-09-12 | SELL | Market Sell | 강명진 Kang Myeong-jin | Managing Director | -5.0K | ₩2,105 | +50.7% | ₩11M ($7K) |
Showing the 50 most recent of 51 filings.
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Vistos. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.